Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome.
Jennifer H CooperriderNoreen FultonAndrew S ArtzRichard A LarsonWendy StockSatyajit KosuriMichael BishopHongtao LiuPublished in: Bone marrow transplantation (2020)